Brief Communication
Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data
M. Muñoz-Torricoa, J. Caminero Lunab, G.B. Miglioric,
, L. D’Ambrosioc,d, J.L. Carrillo-Alduendae, H. Villareal-Velardea, A. Torres-Cruza, H. Flores-Ergaraa, D. Martínez-Mendozaa, C. García-Sanchof, R. Centisc, M.Á. Salazar-Lezamaa, R. Pérez-Padillae
Corresponding author
a Tuberculosis Clinic, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico
b Pneumology Department, University Hospital of Gran Canaria “Dr. Negrin”, Las Palmas, Spain
c WHO Collaborating Centre for TB and Lug Diseases, Maugeri Institute, IRCCS Tradate, Italy
d Public Health Consulting Group, Lugano, Switzerland
e Sleep Clinic, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico
f Department of Epidemiology, National Institute of Respiratory Diseases of Mexico (INER), Mexico City, Mexico
Read
1942
Timeswas read the article
865
Total PDF
1077
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 44 | 32 | 76 |
| 2025 5 | 77 | 53 | 130 |
| 2025 4 | 65 | 44 | 109 |
| 2025 3 | 66 | 34 | 100 |
| 2025 2 | 42 | 38 | 80 |
| 2025 1 | 46 | 40 | 86 |
| 2024 12 | 53 | 46 | 99 |
| 2024 11 | 44 | 47 | 91 |
| 2024 10 | 26 | 34 | 60 |
| 2024 9 | 47 | 22 | 69 |
| 2024 8 | 54 | 33 | 87 |
| 2024 7 | 46 | 33 | 79 |
| 2024 6 | 31 | 25 | 56 |
| 2024 5 | 55 | 41 | 96 |
| 2024 4 | 55 | 24 | 79 |
| 2024 3 | 52 | 20 | 72 |
| 2024 2 | 39 | 32 | 71 |
| 2024 1 | 27 | 34 | 61 |
| 2023 12 | 22 | 25 | 47 |
| 2023 11 | 30 | 43 | 73 |
| 2023 10 | 24 | 34 | 58 |
| 2023 9 | 25 | 35 | 60 |
| 2023 8 | 18 | 15 | 33 |
| 2023 7 | 22 | 29 | 51 |
| 2023 6 | 22 | 11 | 33 |
| 2023 5 | 27 | 32 | 59 |
| 2023 4 | 18 | 9 | 27 |
Show all
